Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors. (Q40468625)

20 September 2017

Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors. (English)

1 reference

20 September 2017

1 reference

Han Ma

1

1 reference

20 September 2017

Vincent Leveque

2

1 reference

20 September 2017

Anniek De Witte

3

1 reference

20 September 2017

Weixing Li

4

1 reference

20 September 2017

Than Hendricks

5

1 reference

20 September 2017

Saundra M Clausen

6

1 reference

20 September 2017

Nick Cammack

7

1 reference

20 September 2017

Klaus Klumpp

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

332

1 reference

20 September 2017

8-15

1 reference

20 September 2017

1

1 reference

Methods of analyzing processivity

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Visualization and functional analysis of RNA-dependent RNA polymerase lattices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Canonical 3'-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

An in vitro Flaviviridae replicase system capable of authentic RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Activation of the CKI-CDK-Rb-E2F pathway in full genome hepatitis C virus-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Oligomerization and Cooperative RNA Synthesis Activity of Hepatitis C Virus RNA-Dependent RNA Polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.024

10.1016/J.VIROL.2004.11.024

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference